-+ 0.00%
-+ 0.00%
-+ 0.00%

Morgan Stanley Maintains Overweight on CME Group, Raises Price Target to $304

Benzinga·04/24/2025 16:44:17
Listen to the news
Morgan Stanley analyst Mike Cyprys maintains CME Group (NASDAQ:CME) with a Overweight and raises the price target from $301 to $304.